• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  08/19/2009
Trade Name:  HIBERIX
Generic or Proper Name (*):  Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) *
Indications Studied:  Active immunization as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b
Therapeutic Category:  Preventive Vaccine
Ages Studied:  13-24 months
Study #:  4
Study Type:  Safety
Study Design:  Open Label
No Patients:  375
No Centers:  45
No Countries:  1